Please login to the form below

Not currently logged in
Email:
Password:

Patients still denied access to new drugs NICE approvals

Patients are still being denied access to NHS treatments despite winning approval byNICE, according to UK media reports

According UK media reports, patients are still being denied access to NHS treatments despite winning approval by the National Institute for Health and Clinical Excellence (NICE).

A Daily Mail report says that the UK government has given Primary Care Trusts (PCT) permission to refuse patients treatments, including a new type of therapy for diabetics as well as special surgery for colon cancer.

Guidelines currently state that novel treatments must be available within three months once approved by the agency.

A new report by the Health Select Committee will recommend a review of the way new treatments are approved.

9th January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics